UPGRADE YOUR TRIALS FOR MDR BY MAY 26, 2021!
WHY WE MUST UPDATE OUR TRIALS If you sponsor a trial that is already ongoing, you must update your safety procedures in accordance with the MDR by the deadline of May 26, 2021. If you are just [...]
Austria: medical device and IVD clinical trials submission process changes during transition to MDR
The Austrian Federal Office for Safety in Health Care (BASG) gave information on a new validation process during the transition to the MDR which will come into force in May 2021.Meditrial manages several studies in Austria and has direct connections [...]
EU: MDCG issued a guidance on standardization for medical devices
The European Commission Medical Device Coordination Group (MDCG) adopted a new standardization request for harmonized European standards in support of the MDR and IVDR after its initial standardization request was rejected last year.Contact Meditrial for a free consultation regarding your device! [...]
EU: The MDCG informs on how to handle class D IVDs during transition to new regulation IVDR
The transition period to the new in vitro diagnostic regulation (IVDR) in the EU will last till next 26 May, 2022. In order to inform device manufacturers, the European Commission´s Medical Device Coordination Group issued a Q&A including information on [...]
EU: Commission drives digital health by establishing new European Health and Digital Executive Agency
The European Commission has established a new executive agency, the European Health and Digital Executive Agency (HaDEA) for digital and health projects. The agency is expected to help Europe emerge stronger from the COVID-19 pandemic.The new HaDEA will be responsible [...]
EU: European Union and Commission launch EU4Health funding program to boost healthcare digitalization and make devices more accessible
As COVID-19 keeps surging throughout many of the European countries, the EU and EU Commission launched EU4Health, the €5.1 billion funding program targeting EU countries, health organisations and NGOs. Aim of the program is to strengthen the resilience of post [...]
Switzerland: New requirements and changes to authorization practice as of May 2021
Swissmedic has recently announced new regulations and requirements for the authorization of clinical trials in Switzerland. Meditrial and its team based in the Zug office manage several studies in Switzerland and has direct connections with Investigators, hospitals and local [...]
EU: EUDAMED UDI/device registration and Certificates and Notified Bodies modules available by September 2021.
The European Commission announced the activation of the modules on UDI/device registration (second module) and on Certificates and Notified Bodies (third module) by September 2021. The first module on Actor registration is available since December 2020. EUDAMED will act as [...]
EU: MDCG issues guidance on harmonised administrative practices and alternative technical solutions until EUDAMED is fully functional
The MDCG issued a new guidance "to Member States and other relevant parties on the application of certain MDR provisions during the absence of EUDAMED. To that end, this guidance intends to describe harmonised administrative practices and alternative technical solutions [...]
EU: The European Commission issues a guidance on management of legacy devices in Eudamed
The European Commission issued a new guidance explaining how legacy devices and in vitro diagnostics (IVDs) will be managed in its Eudamed database, expected to be fully rolled out by May 2022. "Legacy Devices are defined as Medical Devices, Active [...]
